KAISER FOUNDATION HEALTH PLAN INC. for KAISER FOUNDATION HEALTH PLAN INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Legislation and regulation related to health care delivery and health insurance coverage, mental health and substance use disorder care and coverage and electronic health information/technology. H.R.247 - Health Care Affordability Act of 2025 S.46 - Health Care Affordability Act of 2025 H.R.1 - To provide for Reconciliation
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID C BENNETT | — |
| LAIRD D BURNETT | — |
| MARY PRUDENCE FITZPATRICK | — |
Medicare/Medicaid MMM
Legislation and regulation related to the Medicare and Medicare Advantage programs, as well as Medicare and Medicaid coverage, care delivery and financing. House Concurrent Resolution 14 - Establishing the congressional budget for the US government for FY2025. Senate Concurrent Resolution 7 - Establishing the congressional budget for the US government for FY2025. H.R.1 - To provide for Reconciliation
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID C BENNETT | — |
| LAIRD D BURNETT | — |
| MARY PRUDENCE FITZPATRICK | — |
Taxation/Internal Revenue Code TAX
Legislation and regulation affecting tax exempt health care entities and tax treatment of health insurance coverage and care. Extension of the enhanced Advance Premium Tax Credit (APTC) for marketplace health insurance coverage. H.R.1 - To provide for Reconciliation
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID C BENNETT | — |
| LAIRD D BURNETT | — |
| MARY PRUDENCE FITZPATRICK | — |
Defense DEF
Legislation and regulation affecting the TRICARE program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID C BENNETT | — |
| LAIRD D BURNETT | — |
| MARY PRUDENCE FITZPATRICK | — |
Pharmacy PHA
Legislation and regulation regarding pharmaceutical pricing, coverage and care; retail and inpatient pharmacy operations and the role of pharmacy benefit managers. S.527 - Prescription Pricing for the People Act S.1040 - Drug Competition Enhancement Act S.1041 - Affordable Prescriptions for Patients Act S.1097 - Interagency Patent Coordination and Improvement Act S.1095 - Stop STALLING Act S.1096 - Preserve Access to Affordable Generics and Biosimilars Act S.1553 - PREVAIL Act S.1546 - Patent Eligibility Restoration Act of 2025
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID C BENNETT | — |
| LAIRD D BURNETT | — |
| MARY PRUDENCE FITZPATRICK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.